256 related articles for article (PubMed ID: 19809279)
21. Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.
Barillas R; Friehs I; Cao-Danh H; Martinez JF; del Nido PJ
Ann Thorac Surg; 2007 Jul; 84(1):126-33. PubMed ID: 17588398
[TBL] [Abstract][Full Text] [Related]
22. Sevoflurane post-conditioning protects against myocardial reperfusion injury by activation of phosphatidylinositol-3-kinase signal transduction.
Li H; Wang JK; Zeng YM; Yang CX; Chen HT; Wen XJ; Shui CL; Liang H
Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1043-51. PubMed ID: 18505453
[TBL] [Abstract][Full Text] [Related]
23. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
[TBL] [Abstract][Full Text] [Related]
24. Failure to protect against myocardial ischemia-reperfusion injury with sevoflurane postconditioning in old rats in vivo.
Li H; Zhou C; Chen D; Fang N; Yao Y; Li L
Acta Anaesthesiol Scand; 2013 Sep; 57(8):1024-31. PubMed ID: 23848060
[TBL] [Abstract][Full Text] [Related]
25. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
[TBL] [Abstract][Full Text] [Related]
26. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
[TBL] [Abstract][Full Text] [Related]
27. Acute memory phase of sevoflurane preconditioning is associated with sustained translocation of protein kinase C-alpha and epsilon, but not delta, in isolated guinea pig hearts.
Okusa C; Miyamae M; Sugioka S; Kaneda K; Inamura Y; Onishi A; Domae N; Kotani J; Figueredo VM
Eur J Anaesthesiol; 2009 Jul; 26(7):582-8. PubMed ID: 19390447
[TBL] [Abstract][Full Text] [Related]
28. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
[TBL] [Abstract][Full Text] [Related]
29. Ventricular hypertrophy abrogates intralipid-induced cardioprotection by alteration of reperfusion injury salvage kinase/glycogen synthase kinase 3β signal.
Ma LL; Ge HW; Kong FJ; Qian LB; Hu BC; Li Q; Xu L; Liu JQ; Xu YX; Sun RH
Shock; 2014 May; 41(5):435-42. PubMed ID: 24430545
[TBL] [Abstract][Full Text] [Related]
30. Acute PKCdelta inhibition limits ischaemia-reperfusion injury in the aged rat heart: role of GSK-3beta.
Kostyak JC; Hunter JC; Korzick DH
Cardiovasc Res; 2006 May; 70(2):325-34. PubMed ID: 16542646
[TBL] [Abstract][Full Text] [Related]
31. Reactive oxygen species-induced stimulation of 5'AMP-activated protein kinase mediates sevoflurane-induced cardioprotection.
Lamberts RR; Onderwater G; Hamdani N; Vreden MJ; Steenhuisen J; Eringa EC; Loer SA; Stienen GJ; Bouwman RA
Circulation; 2009 Sep; 120(11 Suppl):S10-5. PubMed ID: 19752353
[TBL] [Abstract][Full Text] [Related]
32. Ischemic postconditioning through percutaneous transluminal coronary angioplasty in pigs: roles of PI3K activation.
Ma XJ; Yin HJ; Guo CY; Jiang YR; Wang JS; Shi DZ
Coron Artery Dis; 2012 Jun; 23(4):245-50. PubMed ID: 22421549
[TBL] [Abstract][Full Text] [Related]
33. Cardioprotection of sevoflurane postconditioning by activating extracellular signal-regulated kinase 1/2 in isolated rat hearts.
Chen HT; Yang CX; Li H; Zhang CJ; Wen XJ; Zhou J; Fan YL; Huang T; Zeng YM
Acta Pharmacol Sin; 2008 Aug; 29(8):931-41. PubMed ID: 18664326
[TBL] [Abstract][Full Text] [Related]
34. Protective effects of Phyllanthus emblica against myocardial ischemia-reperfusion injury: the role of PI3-kinase/glycogen synthase kinase 3β/β-catenin pathway.
Thirunavukkarasu M; Selvaraju V; Tapias L; Sanchez JA; Palesty JA; Maulik N
J Physiol Biochem; 2015 Dec; 71(4):623-33. PubMed ID: 26342597
[TBL] [Abstract][Full Text] [Related]
35. The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways.
Gao X; Zhang H; Takahashi T; Hsieh J; Liao J; Steinberg GK; Zhao H
J Neurochem; 2008 May; 105(3):943-55. PubMed ID: 18182053
[TBL] [Abstract][Full Text] [Related]
36. Effect of pressure overload on cardioprotection via PI3K-Akt: comparison of postconditioning, insulin, and pressure unloading.
Mozaffari MS; Liu JY; Schaffer SW
Am J Hypertens; 2010 Jun; 23(6):668-74. PubMed ID: 20300072
[TBL] [Abstract][Full Text] [Related]
37. Hypercholesterolemia abrogates sevoflurane-induced delayed preconditioning against myocardial infarct in rats by alteration of nitric oxide synthase signaling.
Zhang FJ; Ma LL; Wang WN; Qian LB; Yang MJ; Yu J; Chen G; Yu LN; Yan M
Shock; 2012 May; 37(5):485-91. PubMed ID: 22266969
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-374 Exerts Protective Effects by Inhibiting SP1 Through Activating the PI3K/Akt Pathway in Rat Models of Myocardial Ischemia-Reperfusion After Sevoflurane Preconditioning.
Zhang SB; Liu TJ; Pu GH; Li BY; Gao XZ; Han XL
Cell Physiol Biochem; 2018; 46(4):1455-1470. PubMed ID: 29689553
[TBL] [Abstract][Full Text] [Related]
39. Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling.
Raphael J; Gozal Y; Navot N; Zuo Z
J Cardiovasc Pharmacol; 2010 Apr; 55(4):348-57. PubMed ID: 20125034
[TBL] [Abstract][Full Text] [Related]
40. Cardioprotective effects of propofol in isolated ischemia-reperfused guinea pig hearts: role of KATP channels and GSK-3beta.
Kamada N; Kanaya N; Hirata N; Kimura S; Namiki A
Can J Anaesth; 2008 Sep; 55(9):595-605. PubMed ID: 18840589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
